These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity. Lawrence ID, Warner JA, Cohan VL, Hubbard WC, Kagey-Sobotka A, Lichtenstein LM. J Immunol; 1987 Nov 01; 139(9):3062-9. PubMed ID: 2444649 [Abstract] [Full Text] [Related]
11. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. Zuberbier T, Chong SU, Grunow K, Guhl S, Welker P, Grassberger M, Henz BM. J Allergy Clin Immunol; 2001 Aug 01; 108(2):275-80. PubMed ID: 11496246 [Abstract] [Full Text] [Related]
12. Heterogeneity of human mast cells. Schulman ES, Kagey-Sobotka A, MacGlashan DW, Adkinson NF, Peters SP, Schleimer RP, Lichtenstein LM. J Immunol; 1983 Oct 01; 131(4):1936-41. PubMed ID: 6194221 [Abstract] [Full Text] [Related]
14. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJ. J Immunol; 1982 Oct 15; 129(4):1627-31. PubMed ID: 6809826 [Abstract] [Full Text] [Related]
15. Effect of prostaglandin D2 in modulating histamine release from human basophils. Peters SP, Kagey-Sobotka A, MacGlashan DW, Lichtenstein LM. J Pharmacol Exp Ther; 1984 Feb 15; 228(2):400-6. PubMed ID: 6198512 [Abstract] [Full Text] [Related]